エピソード
-
Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.
-
エピソードを見逃しましたか？
-
Medtech Industry Updates: Medikabazaar Rejigs Leadership, 2024 Trends Identified
Medikabazaar has reshuffled its top management following findings from a PwC audit, while recent reports by Clarivate and a 2024 cybersecurity survey highlight emerging breakthrough trends and security concerns in the medtech sector. -
In 2024, Clarivate highlights six significant MedTech trends poised to create new industry opportunities. Additionally, an analysis compares Jin Medical International and Sanara MedTech's performance, while Advanced MedTech reports record revenues for the fiscal year alongside announcing a leadership change.
-
Recent developments in the healthcare and technology sectors show promising progress. Sanara MedTech's stock has seen a rise of 3.6% on NASDAQ. Meanwhile, PEAK:AIO is dedicating efforts towards advancing AI in healthcare. Additionally, IQVIA's SmartSolve® eQMS has been recognized with the 2024 MedTech Breakthrough Award for the Best Use of Artificial Intelligence in Healthcare, highlighting innovations in the industry.
-
Recent updates in the medical technology sector include PROCEPT BioRobotics participating in the Truist Securities MedTech Conference, Boston Scientific's agreement to acquire Silk Road Medical for approximately $1.26 billion, and Salesforce.com launching an AI-powered Life Sciences Cloud to enhance engagements between pharma, MedTech companies, patients, and healthcare professionals.
-
Recent developments in the medical technology field include Theraclion's significant scientific publication that has been positively received by the stock market, Zeta Surgical completing its first clinical study of an AI-powered navigation system, and DePuy Synthes, a Johnson & Johnson company, receiving FDA 510(k) clearance for its VELYS™ Robotic-Assisted Solution to be utilized in unicompartmental knee arthroplasty procedures. These advancements signify notable progress in medical technology and surgical innovation.
-
Here's a summary of recent business headlines: Sanara MedTech announces the resignation of CEO Zach Fleming, with Ron Nixon set to take over the role. Additionally, there are recommendations for two high-yield dividend stocks poised for long-term growth. Vertigenius introduces a new balance-enhancing sensor and app. Scibase prepares for its 2024 Annual General Meeting with a presentation by the Board of Directors.
